Related references
Note: Only part of the references are listed.Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
Kyu Yeon Hur et al.
DIABETES & METABOLISM JOURNAL (2020)
The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones
Min Jeong Kwon et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Soluble Dipeptidyl Peptidase-4 Levels Are Associated with Decreased Renal Function in Patients with Type 2 Diabetes Mellitus
Eun-Hee Cho et al.
DIABETES & METABOLISM JOURNAL (2019)
The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes
Gwang Sil Kim et al.
ENDOCRINOLOGY AND METABOLISM (2019)
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
Kyung-Soo Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria
Yun Mi Choi et al.
ENDOCRINOLOGY AND METABOLISM (2019)
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Mee Kyoung Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Sorim Choung et al.
PPAR RESEARCH (2018)
Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus
Kyung-Soo Kim et al.
DIABETES & METABOLISM JOURNAL (2018)
Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes
J. -Y. Lee et al.
DIABETES & METABOLISM (2018)
Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
Yong-ho Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Soo Lim et al.
DIABETES & METABOLISM JOURNAL (2017)
Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
Kyoung Min Kim et al.
ENDOCRINOLOGY AND METABOLISM (2017)
Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
Kwi-Hyun Bae et al.
ENDOCRINOLOGY AND METABOLISM (2017)
Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis
Soo Lim et al.
ATHEROSCLEROSIS (2015)
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension
S-M Jin et al.
DIABETES OBESITY & METABOLISM (2015)
Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease Chronic Renal Insufficiency Cohort Study
Danielle K. Sandsmark et al.
STROKE (2015)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
DIABETES CARE (2014)
Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
Sin Gon Kim et al.
PLOS ONE (2014)
Clinical Manifestations and Natural History of Diabetic Kidney Disease
Eberhard Ritz
MEDICAL CLINICS OF NORTH AMERICA (2013)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects
Jung Won Kim et al.
CLINICAL THERAPEUTICS (2011)
Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
Pantelis A. Sarafidis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
Toshiharu Ninomiya et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Gang Jee Ko et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
P. A. Sarafidis et al.
KIDNEY INTERNATIONAL (2006)
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria
George L. Bakris et al.
JOURNAL OF HYPERTENSION (2006)
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
DR Matthews et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus:: A double-blind, randomized trial
G Schernthaner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells
BL Guo et al.
DIABETES (2004)
Rosiglitazone reduces urinary albumin excretion in type II diabetes
G Bakris et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells
SB Nicholas et al.
HYPERTENSION (2001)
Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients
T Nakamura et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2000)
Share Paper
